viewTHC Global Group Ltd

THC Global Group in back-to-back trading halts ahead of capital raising news

The recent 12-month production deal with Cannatrek will utilise Cannatrek’s expert cultivation and THC Global’s world-class pharmaceutical production at the Southport Facility.

THC Global Group Ltd - THC Global Group in back-to-back trading halts ahead of capital raising
Cannatrek will supply dried cannabis flower to THC Global for the manufacture into oil-based medicinal cannabis medicines.

THC Global Group Ltd (ASX:THC) has been granted a back-to-back trading halt by the ASX with a capital raising announcement pending.

The company sought the halt in order to consider, plan and execute the capital raising.

This halt will remain in place until the beginning of regular ASX trade on Monday, June 22, or when an announcement is released to the market, whichever occurs earliest.

THC Global's shares last traded at 38 cents and have risen from 21.5 cents at the close on March 31, reaching 44 cents at the close on June 3.

Production deal with Cannatrek

THC recently agreed to a cannabis supply and manufacturing agreement with Cannatrek, a leading grower of medicinal cannabis in Australia.

This agreement takes advantage of THC Global’s Southport’s Facility as a high volume world-class pharmaceutical production facility.

Cannatrek is also developing a new facility in Shepparton, Victoria, which was granted Major Project Status by the Australian Government as a new greenfield development.

The first supply of dried cannabis flower from Cannatrek under this arrangement is expected to begin next quarter with first Cannatrek branded medicines to be released by THC Global in the December quarter of 2020 following production and validation.

Quick facts: THC Global Group Ltd

Price: 0.295 AUD

Market: ASX
Market Cap: $49.57 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...



Full interview: THC Global Group granted GMP Licence for Southport cannabis...

THC Global Group Limited (ASX:THC) chief executive officer Ken Charteris updates Proactive on being granted a licence to manufacture therapeutic goods for the company’s Southport Facility, known as a GMP Licence, by the Australian Therapeutic Goods Administration (TGA). This milestone...

on 29/1/20

2 min read